newsfilter
← Latest News
PR Newswire·

Arcellx to Participate at the Canaccord Genuity 2023 Horizons in Oncology Virtual Conference

REDWOOD CITY, Calif., April 13, 2023 /PRNewswire/ -- Arcellx, Inc. (NASDAQ:ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other